Loading...
Molecular basis for antagonistic activity of anifrolumab, an anti-interferon–α receptor 1 antibody
Anifrolumab (anifrolumab) is an antagonist human monoclonal antibody that targets interferon α receptor 1 (IFNAR1). Anifrolumab has been developed to treat autoimmune diseases and is currently in clinical trials. To decipher the molecular basis of its mechanism of action, we engaged in multiple epit...
Saved in:
| Published in: | MAbs |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622752/ https://ncbi.nlm.nih.gov/pubmed/25606664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1007810 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|